1. Home
  2. SLS vs WRN Comparison

SLS vs WRN Comparison

Compare SLS & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • WRN
  • Stock Information
  • Founded
  • SLS 2012
  • WRN 2006
  • Country
  • SLS United States
  • WRN Canada
  • Employees
  • SLS N/A
  • WRN N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • WRN Metal Mining
  • Sector
  • SLS Health Care
  • WRN Basic Materials
  • Exchange
  • SLS Nasdaq
  • WRN Nasdaq
  • Market Cap
  • SLS 233.7M
  • WRN 248.0M
  • IPO Year
  • SLS N/A
  • WRN N/A
  • Fundamental
  • Price
  • SLS $1.93
  • WRN $2.26
  • Analyst Decision
  • SLS Strong Buy
  • WRN Strong Buy
  • Analyst Count
  • SLS 1
  • WRN 2
  • Target Price
  • SLS $7.00
  • WRN $4.13
  • AVG Volume (30 Days)
  • SLS 2.5M
  • WRN 893.7K
  • Earning Date
  • SLS 11-12-2025
  • WRN 11-06-2025
  • Dividend Yield
  • SLS N/A
  • WRN N/A
  • EPS Growth
  • SLS N/A
  • WRN N/A
  • EPS
  • SLS N/A
  • WRN N/A
  • Revenue
  • SLS N/A
  • WRN N/A
  • Revenue This Year
  • SLS N/A
  • WRN N/A
  • Revenue Next Year
  • SLS N/A
  • WRN N/A
  • P/E Ratio
  • SLS N/A
  • WRN N/A
  • Revenue Growth
  • SLS N/A
  • WRN N/A
  • 52 Week Low
  • SLS $0.77
  • WRN $0.90
  • 52 Week High
  • SLS $2.27
  • WRN $2.40
  • Technical
  • Relative Strength Index (RSI)
  • SLS 59.08
  • WRN 84.49
  • Support Level
  • SLS $1.81
  • WRN $1.87
  • Resistance Level
  • SLS $1.92
  • WRN $2.06
  • Average True Range (ATR)
  • SLS 0.10
  • WRN 0.12
  • MACD
  • SLS 0.03
  • WRN 0.03
  • Stochastic Oscillator
  • SLS 87.67
  • WRN 98.48

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About WRN Western Copper and Gold Corporation

Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).

Share on Social Networks: